SEC Filings

OTCQXZCOR
FormDescriptionDateFormat
SC 13D/AAmendment to a SC 13D filingJul 3, 2019View HTMLDownload DOCDownload PDFDownload XLS
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsJun 7, 2019View HTMLDownload DOCDownload PDFDownload XLS
DOfficial notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the ActFeb 20, 2019View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 14, 2019View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GFeb 14, 2019View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 12, 2019View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GFeb 12, 2019View HTMLDownload DOCDownload PDFDownload XLS
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsFeb 11, 2019View HTMLDownload DOCDownload PDFDownload XLS
SC 13DFiling by person(s) reporting owned shares of common stock in a public company >5%Feb 11, 2019View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GFeb 7, 2019View HTMLDownload DOCDownload PDFDownload XLS
EFFECTNotice from the SEC of registration effectivenessFeb 4, 2019View HTMLDownload DOCDownload PDF
EFFECTNotice from the SEC of registration effectivenessFeb 4, 2019View HTMLDownload DOCDownload PDF
SEC STAFF ACTIONSEC STAFF ACTIONJan 24, 2019View HTMLDownload DOCDownload PDF
T-3/AAmendment to a previously filed T-3Jan 22, 2019View HTMLDownload DOCDownload PDFDownload XLS
25-NSENotification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesJan 8, 2019View HTMLDownload DOCDownload PDF
T-3Application for qualification of trust indentures. Filed pursuant to the Trust Indenture ActDec 7, 2018View HTMLDownload DOCDownload PDFDownload XLS

 

 

CAREERS

Find out more about opportunities with Zyla Life Sciences.

Career Contact
careers@zyla.com

QUICK LINKS

Sign up for Zyla Life Sciences email alerts.

Investor Contact
ir@zyla.com
Media Contact
media@zyla.com

ZYLA LIFE SCIENCES

U.S. Operations
600 Lee Road, Suite 100
Wayne, PA 19087
Tel: 610.833.4200

© Copyright 2019 Zyla Life Sciences
All rights reserved.